Closed
SectorHealthcare
142.65 1.31
24h
Min
140.78
Max
143.2
Income | 100M 108M |
---|---|
Sales | 115M 688M |
P/E Sector Avg | 42.048 35.293 |
EPS | 0.7 |
Profit margin | 15.636 |
Employees | 1,800 |
EBITDA | 129M 153M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +18.64% upside |
Next Earnings | 29 Oct 2025 |
---|
Market Cap | 838M 14B |
---|---|
Previous open | 141.34 |
Previous close | 142.65 |
By Acuity
21%
79%
40 / 371 Healthcare
By Trading Central
Confidence
Weak Bullish Evidence
Past performance is not a reliable indicator of future results.
Price change
By TipRanks
12 Months Forecast
Average 167.17 USD 18.64%
High 200 USD
Low 124 USD
Based on 24 Wall Street analysts offering 12 month price targets forNeurocrine Biosciences Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Very Strong Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$